MX340985B - Compuestos de n-heteroarilo. - Google Patents
Compuestos de n-heteroarilo.Info
- Publication number
- MX340985B MX340985B MX2013003635A MX2013003635A MX340985B MX 340985 B MX340985 B MX 340985B MX 2013003635 A MX2013003635 A MX 2013003635A MX 2013003635 A MX2013003635 A MX 2013003635A MX 340985 B MX340985 B MX 340985B
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- relates
- medicaments
- heteroaryl compounds
- treatments
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- 238000011282 treatment Methods 0.000 abstract 4
- 208000006968 Helminthiasis Diseases 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 208000014837 parasitic helminthiasis infectious disease Diseases 0.000 abstract 2
- 208000030852 Parasitic disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10181553 | 2010-09-29 | ||
| US38846610P | 2010-09-30 | 2010-09-30 | |
| PCT/EP2011/066806 WO2012041873A1 (en) | 2010-09-29 | 2011-09-28 | N-heteroaryl compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013003635A MX2013003635A (es) | 2013-05-22 |
| MX340985B true MX340985B (es) | 2016-08-01 |
Family
ID=44719930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013003635A MX340985B (es) | 2010-09-29 | 2011-09-28 | Compuestos de n-heteroarilo. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8877934B2 (https=) |
| EP (1) | EP2621903B1 (https=) |
| JP (1) | JP5791725B2 (https=) |
| KR (1) | KR101916481B1 (https=) |
| CN (2) | CN103189356B (https=) |
| AR (1) | AR083200A1 (https=) |
| AU (1) | AU2011310592B2 (https=) |
| BR (1) | BR112013006030B1 (https=) |
| CA (1) | CA2811369C (https=) |
| CO (1) | CO6710926A2 (https=) |
| ES (1) | ES2622881T3 (https=) |
| HU (1) | HUE034042T2 (https=) |
| MX (1) | MX340985B (https=) |
| NZ (1) | NZ607580A (https=) |
| PL (1) | PL2621903T3 (https=) |
| RU (1) | RU2596185C2 (https=) |
| WO (1) | WO2012041873A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10096073B2 (en) | 2011-05-13 | 2018-10-09 | The Climate Corporation | Systems to prescribe and deliver fertilizer over agricultural fields and related methods |
| US10842144B2 (en) | 2011-05-13 | 2020-11-24 | The Climate Corporation | Method and system to map biological pests in agricultural fields using remotely-sensed data for field scouting and targeted chemical application |
| AU2013241853B2 (en) | 2012-03-28 | 2017-11-09 | Intervet International B.V. | Heteroaryl compounds with A-cyclic bridging unit |
| EP2931043B1 (en) * | 2012-12-13 | 2017-08-02 | Dow AgroSciences LLC | Process for the preparation of 4-amino-5-fluoro-3-chloro-6-(substituted)picolinates |
| US9096526B2 (en) * | 2012-12-13 | 2015-08-04 | Dow Agrosciences Llc | Processes for the preparation of 4-amino-3-halo-6-(substituted)picolinates and 4-amino-5-fluoro-3-halo-6-(substituted)picolinates |
| WO2015177179A1 (en) | 2014-05-21 | 2015-11-26 | Intervet International B.V. | Improved process for preparing substituted crotonic acids |
| CR20170077A (es) | 2014-08-04 | 2017-06-26 | Nuevolution As | Derivados de heterociclilo opcionalmente condensados de pirimidina útiles para el tratamiento de enfermedades inflamatorias, metabólicas, oncológicas y autoinmunitarias |
| EP3394031A1 (en) * | 2015-12-23 | 2018-10-31 | Intervet International B.V. | Improved process for making crotonylaminopyridines |
| AR111260A1 (es) | 2017-03-31 | 2019-06-19 | Intervet Int Bv | Formulación farmacéutica de la sal de crotonil amino piridina |
| CN113242853B (zh) * | 2018-12-21 | 2025-06-24 | 赛拓有限责任公司 | 用于制备2-烷氧基-4-氨基-5-甲基-吡啶和/或2-烷氧基-4-烷基氨基-5-甲基-吡啶的方法 |
| BR112022012130A2 (pt) | 2019-12-18 | 2022-08-30 | Intervet Int Bv | Compostos antelmínticos compreendendo uma estrutura azaindólica |
| UY38994A (es) | 2019-12-20 | 2021-07-30 | Nuevolution As | Compuestos activos frente a receptores nucleares |
| MX2022007265A (es) | 2019-12-20 | 2022-09-09 | Nuevolution As | Compuestos activos frente a receptores nucleares. |
| CN110960485B (zh) * | 2020-01-06 | 2021-02-02 | 安丘市人民医院 | 一种用于治疗角膜炎的药物及其制备方法 |
| AU2021245397A1 (en) | 2020-03-31 | 2022-10-20 | Nuevolution A/S | Compounds active towards nuclear receptors |
| WO2021198956A1 (en) | 2020-03-31 | 2021-10-07 | Nuevolution A/S | Compounds active towards nuclear receptors |
| WO2025152919A1 (en) * | 2024-01-15 | 2025-07-24 | Impact Therapeutics (Shanghai) , Inc. | Crystal forms of a weel inhibitor and preparation method thereof |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1131225A (en) * | 1977-03-02 | 1982-09-07 | Werner Muller | Dyestuffs as affine residues |
| DE2709094C2 (de) * | 1977-03-02 | 1984-11-22 | Boehringer Mannheim Gmbh, 6800 Mannheim | Adsorbens für die affinitätsspezifische Trennung von Nukleinsäuren, Verfahren zu seiner Herstellung und seine Verwendung |
| DE2758036A1 (de) * | 1977-12-24 | 1979-07-05 | Boehringer Mannheim Gmbh | Adsorbens fuer die affinitaetsspezifische trennung von makromolekularen stoffen, verfahren zu seiner herstellung und seine verwendung |
| US5098462A (en) | 1985-08-20 | 1992-03-24 | Sandoz Ltd. | Substituted semi-carbazones and related compounds |
| WO1992000964A1 (fr) | 1990-07-05 | 1992-01-23 | Nippon Soda Co., Ltd. | Derive d'amine |
| JP2986187B2 (ja) * | 1990-08-31 | 1999-12-06 | コニカ株式会社 | 感熱転写材料による画像形成方法 |
| FR2683817B1 (fr) * | 1991-11-18 | 1994-02-25 | Upsa Laboratoires | Nouveaux derives d'alpha-amino n-pyridyl benzene propanamide, leurs procedes de preparation, compositions pharmaceutiques les contenant. |
| US5399582A (en) | 1993-11-01 | 1995-03-21 | Merck & Co., Inc. | Antiparasitic agents |
| US5595991A (en) | 1995-03-20 | 1997-01-21 | Merck & Co., Inc. | Anthelmintic use of nodulisporic acid and analogs thereof |
| PL185563B1 (pl) | 1995-03-20 | 2003-06-30 | Merck & Co Inc | Pochodne kwasu nodulisporowego oraz zawierające je kompozycje farmaceutyczne |
| US5962499A (en) | 1995-03-20 | 1999-10-05 | Merck & Co., Inc. | Nodulisporic acid derivatives |
| US6221894B1 (en) | 1995-03-20 | 2001-04-24 | Merck & Co., Inc. | Nodulisporic acid derivatives |
| WO1997029079A1 (en) * | 1996-02-06 | 1997-08-14 | Japan Tobacco Inc. | Novel compounds and pharmaceutical use thereof |
| DE19624668A1 (de) * | 1996-06-20 | 1998-02-19 | Klinge Co Chem Pharm Fab | Verwendung von Pyridylalkan-, Pyridylalken- bzw. Pyridylalkinsäureamiden |
| DE19624659A1 (de) * | 1996-06-20 | 1998-01-08 | Klinge Co Chem Pharm Fab | Neue Pyridylalken- und Pyridylalkinsäureamide |
| US5834260A (en) | 1996-08-30 | 1998-11-10 | Merck & Co., Inc. | Antiparasitic agents |
| UA77200C2 (en) | 2001-08-07 | 2006-11-15 | Wyeth Corp | Antineoplastic combination of cci-779 and bkb-569 |
| PL369856A1 (en) * | 2001-12-21 | 2005-05-02 | Anormed Inc. | Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| TW200418863A (en) * | 2002-10-17 | 2004-10-01 | Upjohn Co | Novel anthelmintic and insecticidal compositions |
| KR100470076B1 (ko) | 2002-11-27 | 2005-02-05 | 씨제이 주식회사 | 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물 |
| CN1735603A (zh) | 2002-12-06 | 2006-02-15 | 东丽株式会社 | 苯并吗啉衍生物 |
| US7361689B2 (en) | 2003-12-31 | 2008-04-22 | Schering-Plough Animal Health Corporation | Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof |
| BRPI0418328A (pt) | 2003-12-31 | 2007-05-02 | Schering Plough Ltd | controle de parasitas em animais pelo uso de derivados de imidazo [1,2-b]piridazina |
| AU2005219788B2 (en) | 2004-03-05 | 2010-06-03 | Nissan Chemical Corporation | Isoxazoline-substituted benzamide compound and noxious organism control agent |
| WO2006010084A2 (en) * | 2004-07-06 | 2006-01-26 | Segev Laboratories Limited | A system for delivering therapeutic agents into living cells and cell nuclei |
| AU2005286723A1 (en) | 2004-09-23 | 2006-03-30 | Schering-Plough Pty. Limited | Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives |
| DE602005017419D1 (de) | 2004-11-19 | 2009-12-10 | Schering Plough Ltd | Kontrolle von parasiten bei tieren mittels verwendung von parasitiziden 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitril-derivaten |
| CN102633730A (zh) | 2004-12-03 | 2012-08-15 | 先灵公司 | 作为cb1拮抗剂的取代哌嗪 |
| BRPI0518942A2 (pt) * | 2004-12-07 | 2008-12-16 | Merial Ltd | 1-fenil-3-piperazina-pirazàis e composiÇÕes pesticidas de matÉria dos mesmos |
| US20060147847A1 (en) * | 2004-12-30 | 2006-07-06 | Guire Patrick E | Antimicrobial compositions and methods |
| WO2006105056A2 (en) * | 2005-03-28 | 2006-10-05 | Fmc Corporation | Insecticidal 2,4-diaminoquinazolines and related derivatives |
| WO2006127203A2 (en) | 2005-05-25 | 2006-11-30 | Wyeth | Methods of synthesizing 6-alkylaminoquinoline derivatives |
| CA2609574A1 (en) | 2005-06-09 | 2006-12-21 | Schering-Plough Ltd. | Control of parasites in animals by n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives |
| WO2007026965A1 (ja) | 2005-09-02 | 2007-03-08 | Nissan Chemical Industries, Ltd. | イソキサゾリン置換ベンズアミド化合物及び有害生物防除剤 |
| JP2009519937A (ja) | 2005-12-14 | 2009-05-21 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | 無脊椎有害生物防除用イソオキサゾリン |
| TW200803740A (en) | 2005-12-16 | 2008-01-16 | Du Pont | 5-aryl isoxazolines for controlling invertebrate pests |
| TWI412322B (zh) | 2005-12-30 | 2013-10-21 | Du Pont | 控制無脊椎害蟲之異唑啉 |
| BRPI0707091B8 (pt) | 2006-03-10 | 2018-02-14 | Nissan Chemical Ind Ltd | composto de isoxalina e benzaldoxima substituído ou um sal do mesmo; pesticida, agroquímico, endo- ou ecto-parasiticidapara mamíferos ou pássaros, inseticida e acaricida contendo como um ou mais ingredientes ativos selecionados a partir do composto de isoxalina substituído e o sal do mesmo |
| DE102006015470A1 (de) | 2006-03-31 | 2007-10-04 | Bayer Cropscience Ag | Substituierte Enaminocarbonylverbindungen |
| ATE476424T1 (de) * | 2006-04-20 | 2010-08-15 | Hoffmann La Roche | Diazepanderivate als modulatoren von chemokinrezeptoren |
| JPWO2007125984A1 (ja) | 2006-04-28 | 2009-09-10 | 日本農薬株式会社 | イソキサゾリン誘導体及び有害生物防除剤並びにその使用方法 |
| JP2008044880A (ja) | 2006-08-15 | 2008-02-28 | Bayer Cropscience Ag | 殺虫性イソオキサゾリン類 |
| DE102006039283A1 (de) * | 2006-08-22 | 2008-02-28 | Henkel Kgaa | Formfixierung faserhaltiger Materialien durch Polymere |
| EP1900731A1 (de) | 2006-09-07 | 2008-03-19 | Bayer Schering Pharma Aktiengesellschaft | N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren |
| EP1903038A1 (de) | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | N-(1-Hetaryl-piperidin-4-yl)-(het)arylamide als EP2-Rezeptor Modulatoren |
| US8372867B2 (en) | 2007-04-10 | 2013-02-12 | Bayer Cropscience Ag | Insecticidal aryl isoxazoline derivatives |
| JP2010523639A (ja) | 2007-04-12 | 2010-07-15 | エフ．ホフマン−ラ ロシュ アーゲー | 医薬化合物 |
| TW200900398A (en) | 2007-05-31 | 2009-01-01 | Du Pont | 3-cyano-4-triazolyl phenylisoxazoline invertebrate pest control agents |
| TWI430995B (zh) | 2007-06-26 | 2014-03-21 | Du Pont | 萘異唑啉無脊椎有害動物控制劑 |
| ES2549731T3 (es) | 2007-06-27 | 2015-11-02 | E. I. Du Pont De Nemours And Company | Método para el control de plagas en animales |
| CN101778833A (zh) | 2007-08-10 | 2010-07-14 | 日本曹达株式会社 | 含氮杂环化合物和有害生物防除剂 |
| CN101801940B (zh) | 2007-09-10 | 2013-04-10 | 日产化学工业株式会社 | 取代异*唑啉化合物和有害生物防除剂 |
| US8367584B2 (en) | 2007-10-03 | 2013-02-05 | E.I. Du Pont De Nemours And Company | Naphthalene isoxazoline compounds for control of invertebrate pests |
| WO2009051956A2 (en) | 2007-10-16 | 2009-04-23 | E. I. Du Pont De Nemours And Company | Pyrazole-substituted isoxazoline insecticides |
| CN101284812A (zh) | 2008-06-05 | 2008-10-15 | 中山大学 | 他克林-阿魏酸杂联体,其制备方法及其药物组合物 |
| US8809268B2 (en) | 2008-10-29 | 2014-08-19 | The Regents Of The University Of California | Combination therapy to combat helminth resistance |
| US8007761B2 (en) | 2008-12-24 | 2011-08-30 | Praxair Technology, Inc. | Carbon dioxide emission reduction method |
-
2011
- 2011-09-28 CN CN201180052605.XA patent/CN103189356B/zh not_active Expired - Fee Related
- 2011-09-28 JP JP2013530709A patent/JP5791725B2/ja not_active Expired - Fee Related
- 2011-09-28 RU RU2013119681/04A patent/RU2596185C2/ru active
- 2011-09-28 CN CN201510648665.8A patent/CN105294549B/zh not_active Expired - Fee Related
- 2011-09-28 NZ NZ607580A patent/NZ607580A/en not_active IP Right Cessation
- 2011-09-28 PL PL11761595T patent/PL2621903T3/pl unknown
- 2011-09-28 BR BR112013006030-1A patent/BR112013006030B1/pt not_active IP Right Cessation
- 2011-09-28 WO PCT/EP2011/066806 patent/WO2012041873A1/en not_active Ceased
- 2011-09-28 EP EP11761595.5A patent/EP2621903B1/en active Active
- 2011-09-28 HU HUE11761595A patent/HUE034042T2/en unknown
- 2011-09-28 CA CA2811369A patent/CA2811369C/en not_active Expired - Fee Related
- 2011-09-28 AR ARP110103573A patent/AR083200A1/es not_active Application Discontinuation
- 2011-09-28 ES ES11761595.5T patent/ES2622881T3/es active Active
- 2011-09-28 AU AU2011310592A patent/AU2011310592B2/en not_active Ceased
- 2011-09-28 KR KR1020137007888A patent/KR101916481B1/ko not_active Expired - Fee Related
- 2011-09-28 US US13/876,724 patent/US8877934B2/en active Active
- 2011-09-28 MX MX2013003635A patent/MX340985B/es active IP Right Grant
-
2013
- 2013-04-17 CO CO13099093A patent/CO6710926A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2596185C2 (ru) | 2016-08-27 |
| AU2011310592B2 (en) | 2015-01-22 |
| EP2621903B1 (en) | 2017-03-01 |
| CO6710926A2 (es) | 2013-07-15 |
| NZ607580A (en) | 2015-01-30 |
| JP5791725B2 (ja) | 2015-10-07 |
| CA2811369C (en) | 2019-09-03 |
| RU2013119681A (ru) | 2014-11-10 |
| KR101916481B1 (ko) | 2018-11-07 |
| ES2622881T3 (es) | 2017-07-07 |
| PL2621903T3 (pl) | 2017-08-31 |
| EP2621903A1 (en) | 2013-08-07 |
| AR083200A1 (es) | 2013-02-06 |
| AU2011310592A1 (en) | 2013-03-14 |
| CN103189356B (zh) | 2015-11-25 |
| JP2014500235A (ja) | 2014-01-09 |
| CN103189356A (zh) | 2013-07-03 |
| BR112013006030A2 (pt) | 2016-06-07 |
| WO2012041873A1 (en) | 2012-04-05 |
| HUE034042T2 (en) | 2018-01-29 |
| US8877934B2 (en) | 2014-11-04 |
| US20130196993A1 (en) | 2013-08-01 |
| CN105294549B (zh) | 2017-12-26 |
| KR20130139889A (ko) | 2013-12-23 |
| CN105294549A (zh) | 2016-02-03 |
| MX2013003635A (es) | 2013-05-22 |
| BR112013006030B1 (pt) | 2020-03-17 |
| CA2811369A1 (en) | 2012-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX340985B (es) | Compuestos de n-heteroarilo. | |
| UA109991C2 (xx) | Карбаматні сполуки, їх отримання і застосування | |
| PH12015501385A1 (en) | Autotaxin inhibitors | |
| MY198204A (en) | Cyclic Boronic Acid Ester Derivatives And Therapeutic Uses Thereof | |
| UA109661C2 (uk) | Фармацевтична композиція співкристалів трамадолу і коксибів | |
| PH12015500274A1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
| PH12015500713A1 (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
| MX359989B (es) | Fármacos antivirales para el tratamiento de la infección por arenavirus. | |
| UA109010C2 (en) | Morpholino pyrividines and their use in therapy | |
| EA201591003A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| MX2011009847A (es) | Agentes antihelminticos y su uso. | |
| EP4371615A3 (en) | Treatment of amd using aav sflt-1 | |
| GB2511685A (en) | Muscarinic m1 receptor agonists | |
| EA201390198A1 (ru) | Гетероциклическое соединение | |
| PH12015501609A1 (en) | Phenicol antibacterials | |
| JO3122B1 (ar) | مشتقات إسترا-5،3،1(10)، 16- تترايين-3- كربوكساميد، عمليات لتحضيرها، مستحضرات دوائية تشتمل عليها واستخدامها لتحضير أدوية | |
| EA201600434A1 (ru) | Применение производных бензимидазолпролина | |
| IN2015DN02109A (https=) | ||
| EA201270547A1 (ru) | Фармацевтическая композиция | |
| EA201390764A1 (ru) | Фармацевтические композиции | |
| HK1193804A1 (zh) | 经芳基或杂芳基取代的苯化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |